0000899243-21-046333.txt : 20211130 0000899243-21-046333.hdr.sgml : 20211130 20211130183151 ACCESSION NUMBER: 0000899243-21-046333 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211124 FILED AS OF DATE: 20211130 DATE AS OF CHANGE: 20211130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patel Samir Rashmikant CENTRAL INDEX KEY: 0001702447 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-49908 FILM NUMBER: 211460752 MAIL ADDRESS: STREET 1: 1111 MAIN STREET STREET 2: SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2021-11-24 2021-11-29 1 0001175680 CytoDyn Inc. CYDY 0001702447 Patel Samir Rashmikant 1111 MAIN STREET SUITE 660 VANCOUVER WA 98660 1 0 0 0 Non-qualified Stock Option 1.39 2021-11-24 4 D 0 225000 D 2031-10-18 Common Stock 225000 0 D Non-qualified Stock Option 1.39 2021-11-24 4 A 0 112500 A 2031-10-18 Common Stock 112500 112500 D Non-qualified Stock Option 6.15 2021-11-24 4 D 0 225000 D 2030-06-25 Common Stock 225000 0 D Non-qualified Stock Option 6.15 2021-11-24 4 A 0 225000 A 2030-06-25 Common Stock 225000 225000 D Non-qualified Stock Option 2.25 2021-11-24 4 D 0 12329 D 2020-05-31 2030-04-17 Common Stock 12329 0 D Non-qualified Stock Option 2.25 2021-11-24 4 A 0 12329 A 2020-05-31 2030-04-17 Common Stock 12329 12329 D The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on December 1, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service. 56,250 shares vested on August 31, 2020; the balance vested in equal amounts on November 30, 2020, February 28, 2021, and May 31, 2021. /s/ Antonio Migliarese, Attorney-In-Fact 2021-11-30